Kodiak Sciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Hello, everyone. My name is Gena Wang. I'm smid-cap biotech analyst at Barclays. Welcome to our second virtual Global Healthcare Conference. First, I wish everyone to stay healthy, and I would like to thank all the participants, investors, companies and especially our event team, our corporate access team who made this virtual healthcare conference possible.
With that, I would like to introduce our next presenter, Victor Perlroth from -- Chief Executive Officer from Kodiak. Victor, I hand over to you.
Thank you so much, Gena, and thanks to the Barclays team for having us at the conference.
We'll move in to our presentation. Thank you very much. I'm the Chief Executive Officer of Kodiak Sciences. We're an ophthalmology-focused biotech, in particular, focused on new treatments for diseases in retina.
Please note, there'll be some forward-looking statements made in the discussion.
So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |